Cumberland Pharmaceuticals
CPIX
28 hedge funds and large institutions have $8.36M invested in Cumberland Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
2.09% less ownership
Funds ownership: 21.62% → 19.53% (-2.1%)
10% less funds holding
Funds holding: 31 → 28 (-3)
14% less capital invested
Capital invested by funds: $9.77M → $8.36M (-$1.41M)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$95.8K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$51.8K |
| 3 |
BAM
Berkshire Asset Management
Wilkes Barre,
Pennsylvania
|
+$15.7K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$5.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$589K |
| 2 |
Renaissance Technologies
New York
|
-$152K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$115K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$52K |
| 5 |
MHS
M Holdings Securities
Portland,
Oregon
|
-$33K |
CPIX Hedge Fund Activity: Q2 2021 in Review
28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2021, worth a combined $8.36M — down 14% from $9.77M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPIX and 0 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 4 added.
The largest buyer was BlackRock, adding an estimated $95.8K. The largest seller was Ariel Investments, cutting an estimated $589K.
- 28 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2021, down from 31 in Q1 2021.
- Funds reported $8.36M of Cumberland Pharmaceuticals stock for Q2 2021, down 14% quarter-over-quarter.
- 0 funds opened new Cumberland Pharmaceuticals positions in Q2 2021 and 3 closed out, a net change of -3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q2 2021 was BlackRock, an estimated $95.8K added.
- The largest Cumberland Pharmaceuticals seller in Q2 2021 was Ariel Investments, an estimated $589K sold.
Based on aggregated 13F filings for Q2 2021.